• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.PEDF 的抗渗透功能涉及阻断 MAP 激酶/GSK/β-连环蛋白信号通路和 uPAR 表达。
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3273-80. doi: 10.1167/iovs.08-2878. Epub 2010 Jan 20.
2
Blockade of VEGF-induced GSK/β-catenin signaling, uPAR expression and increased permeability by dominant negative p38α.通过显性负性 p38α 阻断 VEGF 诱导的 GSK/β-catenin 信号、uPAR 表达和通透性增加。
Exp Eye Res. 2012 Jul;100:101-8. doi: 10.1016/j.exer.2012.03.011. Epub 2012 Apr 30.
3
PEDF regulates vascular permeability by a γ-secretase-mediated pathway.PEDF 通过 γ-分泌酶介导的途径调节血管通透性。
PLoS One. 2011;6(6):e21164. doi: 10.1371/journal.pone.0021164. Epub 2011 Jun 17.
4
Diabetes-induced superoxide anion and breakdown of the blood-retinal barrier: role of the VEGF/uPAR pathway.糖尿病引起的超氧阴离子和血视网膜屏障的破坏:VEGF/uPAR 通路的作用。
PLoS One. 2013 Aug 7;8(8):e71868. doi: 10.1371/journal.pone.0071868. eCollection 2013.
5
Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro.在体外高糖条件下,PEDF 通过线粒体 ROS 通路抑制 JAK2/STAT3 介导的 VEGF 上调。
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):64-71. doi: 10.1167/iovs.09-3511. Epub 2009 Aug 20.
6
Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.色素上皮衍生因子抑制糖基化终产物诱导的视网膜血管通透性增加。
Biochimie. 2010 Aug;92(8):1040-51. doi: 10.1016/j.biochi.2010.05.004. Epub 2010 May 12.
7
Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.诺里在血管内皮生长因子诱导的通透性后恢复血视网膜屏障特性。
J Biol Chem. 2020 Apr 3;295(14):4647-4660. doi: 10.1074/jbc.RA119.011273. Epub 2020 Feb 21.
8
VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor.血管内皮生长因子诱导培养的内皮细胞的细胞旁通透性涉及尿激酶及其受体。
FASEB J. 2003 Apr;17(6):752-4. doi: 10.1096/fj.02-0484fje. Epub 2003 Feb 19.
9
Pigment epithelium-derived factor inhibits vascular endothelial growth factor-and interleukin-1beta-induced vascular permeability and angiogenesis in retinal endothelial cells.色素上皮衍生因子抑制血管内皮生长因子和白细胞介素-1β诱导的视网膜内皮细胞血管通透性和血管生成。
Vascul Pharmacol. 2010 Jan-Feb;52(1-2):84-94. doi: 10.1016/j.vph.2009.12.002. Epub 2009 Dec 16.
10
Pigment epithelium-derived factor inhibits erythropoietin-induced retinal endothelial cell angiogenesis by suppression of PI3K/Akt pathway.色素上皮衍生因子通过抑制 PI3K/Akt 通路抑制促红细胞生成素诱导的视网膜内皮细胞血管生成。
Exp Eye Res. 2010 Jun;90(6):726-33. doi: 10.1016/j.exer.2010.03.005. Epub 2010 Mar 16.

引用本文的文献

1
Functional Roles of Pigment Epithelium-Derived Factor in Retinal Degenerative and Vascular Disorders: A Scoping Review.色素上皮衍生因子在视网膜退行性和血管性疾病中的功能作用:一项范围综述
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):41. doi: 10.1167/iovs.65.14.41.
2
Retinal Vein Occlusion-Background Knowledge and Foreground Knowledge Prospects-A Review.视网膜静脉阻塞——背景知识与前沿知识展望——综述
J Clin Med. 2024 Jul 5;13(13):3950. doi: 10.3390/jcm13133950.
3
Chimpanzee adenovirus-mediated multiple gene therapy for age-related macular degeneration.黑猩猩腺病毒介导的针对年龄相关性黄斑变性的多基因疗法。
iScience. 2023 Sep 16;26(10):107939. doi: 10.1016/j.isci.2023.107939. eCollection 2023 Oct 20.
4
Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.色素上皮衍生因子(PEDF)与转化生长因子-β(TGF-β)之间的拮抗作用导致VI型成骨不全症的骨骼和血管发病机制。
J Bone Miner Res. 2022 May;37(5):925-937. doi: 10.1002/jbmr.4540. Epub 2022 Apr 13.
5
Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis.糖尿病和葡萄膜炎介质对人视网膜内皮屏障体外调节的不同机制
Life (Basel). 2021 Dec 27;12(1):33. doi: 10.3390/life12010033.
6
Wnt Signaling in Inner Blood-Retinal Barrier Maintenance.Wnt 信号在维持内血液视网膜屏障中的作用。
Int J Mol Sci. 2021 Nov 2;22(21):11877. doi: 10.3390/ijms222111877.
7
Antiangiogenic therapy in diabetic nephropathy: A double‑edged sword (Review).抗血管生成治疗在糖尿病肾病中的应用:一把双刃剑(综述)。
Mol Med Rep. 2021 Apr;23(4). doi: 10.3892/mmr.2021.11899. Epub 2021 Feb 8.
8
Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.糖尿病性视网膜病变中血视网膜屏障细胞连接的调控。
Pharmacol Res. 2020 Nov;161:105115. doi: 10.1016/j.phrs.2020.105115. Epub 2020 Aug 1.
9
Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization.色素上皮衍生因子作为脉络膜新生血管治疗药物的可能性。
Oxid Med Cell Longev. 2020 Mar 6;2020:8941057. doi: 10.1155/2020/8941057. eCollection 2020.
10
Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.色素上皮衍生因子改善正常和缺血小鼠脑的血脑屏障旁通透性。
Cell Mol Neurobiol. 2020 Jul;40(5):751-764. doi: 10.1007/s10571-019-00770-9. Epub 2019 Dec 20.

本文引用的文献

1
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes.尿激酶/尿激酶受体系统的一种肽抑制剂可抑制糖尿病患者血视网膜屏障的改变。
FASEB J. 2008 Sep;22(9):3310-7. doi: 10.1096/fj.08-110155. Epub 2008 Jun 16.
2
MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.在人肝癌细胞中,MEK/ERK依赖的uPAR表达通过P70S6K磷酸化对细胞运动是必需的。
J Cell Physiol. 2007 Aug;212(2):526-36. doi: 10.1002/jcp.21049.
3
PEDF induces apoptosis in human endothelial cells by activating p38 MAP kinase dependent cleavage of multiple caspases.色素上皮衍生因子通过激活依赖p38丝裂原活化蛋白激酶的多种半胱天冬酶裂解来诱导人内皮细胞凋亡。
Biochem Biophys Res Commun. 2006 Oct 6;348(4):1288-95. doi: 10.1016/j.bbrc.2006.07.188. Epub 2006 Aug 7.
4
Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.色素上皮衍生因子下调血管内皮生长因子(VEGF)的表达,并抑制糖尿病视网膜病变中VEGF与VEGF受体2的结合。
J Mol Endocrinol. 2006 Aug;37(1):1-12. doi: 10.1677/jme.1.02008.
5
Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.色素上皮衍生因子通过阻断活性氧介导的血管内皮生长因子表达,抑制晚期糖基化终产物诱导的视网膜血管高通透性。
J Biol Chem. 2006 Jul 21;281(29):20213-20. doi: 10.1074/jbc.M602110200. Epub 2006 May 17.
6
Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells.色素上皮衍生因子通过激活培养的视网膜色素上皮细胞中的细胞外信号调节激酶来抑制氧化应激诱导的细胞死亡。
Life Sci. 2006 Jul 4;79(6):545-50. doi: 10.1016/j.lfs.2006.01.041. Epub 2006 Feb 28.
7
Pigment epithelium-derived factor protects retinal pigment epithelium from oxidant-mediated barrier dysfunction.色素上皮衍生因子可保护视网膜色素上皮免受氧化应激介导的屏障功能障碍。
Biochem Biophys Res Commun. 2006 Apr 7;342(2):372-8. doi: 10.1016/j.bbrc.2006.01.164. Epub 2006 Feb 8.
8
uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in the MDA-MB-231 breast carcinoma cell line.缺氧条件下uPAR的表达取决于iNOS调节的MDA-MB-231乳腺癌细胞系中的ERK磷酸化。
Cell Res. 2006 Jan;16(1):75-81. doi: 10.1038/sj.cr.7310010.
9
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema.玻璃体内色素上皮衍生因子和血管内皮生长因子水平与糖尿病性黄斑水肿相关。
Ophthalmology. 2006 Feb;113(2):294-301. doi: 10.1016/j.ophtha.2005.10.030. Epub 2006 Jan 10.
10
Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor.色素上皮衍生因子(PEDF)是一种内源性抗炎因子。
FASEB J. 2006 Feb;20(2):323-5. doi: 10.1096/fj.05-4313fje. Epub 2005 Dec 20.

PEDF 的抗渗透功能涉及阻断 MAP 激酶/GSK/β-连环蛋白信号通路和 uPAR 表达。

Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.

机构信息

VA Medical Center, Augusta, Georgia, USA.

出版信息

Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3273-80. doi: 10.1167/iovs.08-2878. Epub 2010 Jan 20.

DOI:10.1167/iovs.08-2878
PMID:20089873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2891479/
Abstract

PURPOSE

Pigment epithelium-derived factor (PEDF) is a potent inhibitor of vascular endothelial growth factor (VEGF)-induced endothelial permeability. The goal of this study was to understand the mechanism by which PEDF blocks VEGF-induced increases in vascular permeability.

METHODS

The paracellular permeability of bovine retinal endothelial (BRE) cells was measured by assaying transendothelial cell electrical resistance and tracer flux. Western blot analysis was used to show phosphorylation of VEGFR2, MAP kinases, and glycogen synthase kinase 3 (GSK3)-beta. Confocal imaging and Western blot analysis were used to determine subcellular distribution of beta-catenin. Real-time RT-PCR and Western blot analysis were used to quantify urokinase plasminogen activator receptor (uPAR) expression.

RESULTS

PEDF blocked VEGF-induced phosphorylation of extracellular signal-regulated kinase (ERK), p38 MAP kinase, the p38 substrate MAP kinase-activated protein kinase-2 (MAPKAPK-2), and GSK3-beta, but it had no effect on the phosphorylation of VEGFR2. In addition, the VEGF-induced transcriptional activation of beta-catenin and uPAR expression were blocked by PEDF and by inhibitors of p38 and MEK. Finally, the VEGF-induced increase in permeability was blocked by both PEDF and the same kinase inhibitors.

CONCLUSIONS

The data suggest that p38 MAP kinase and ERK act upstream of GSK/beta-catenin in VEGF-induced activation of the uPA/uPAR system and that PEDF-mediated inhibition of the VEGF-induced increase in vascular permeability involves blockade of this pathway. These findings are important for developing precise and potent therapies for treatment of diseases characterized by vascular barrier dysfunction.

摘要

目的

色素上皮衍生因子(PEDF)是一种有效的血管内皮生长因子(VEGF)诱导的内皮通透性抑制剂。本研究旨在探讨 PEDF 阻断 VEGF 诱导的血管通透性增加的机制。

方法

通过测定跨内皮细胞电阻和示踪剂通量来测量牛视网膜内皮(BRE)细胞的旁细胞通透性。Western blot 分析用于显示 VEGFR2、MAP 激酶和糖原合酶激酶 3(GSK3)-β的磷酸化。共聚焦成像和 Western blot 分析用于确定β-连环蛋白的亚细胞分布。实时 RT-PCR 和 Western blot 分析用于定量尿激酶型纤溶酶原激活物受体(uPAR)的表达。

结果

PEDF 阻断了 VEGF 诱导的细胞外信号调节激酶(ERK)、p38 MAP 激酶、p38 底物 MAP 激酶激活蛋白激酶-2(MAPKAPK-2)和 GSK3-β的磷酸化,但对 VEGFR2 的磷酸化没有影响。此外,PEDF 和 p38 和 MEK 的抑制剂阻断了 VEGF 诱导的β-连环蛋白和 uPAR 表达的转录激活。最后,PEDF 和相同的激酶抑制剂均可阻断 VEGF 诱导的通透性增加。

结论

数据表明,p38 MAP 激酶和 ERK 在 VEGF 诱导的 uPA/uPAR 系统激活中位于 GSK/β-连环蛋白的上游,而 PEDF 介导的 VEGF 诱导的血管通透性增加的抑制涉及该途径的阻断。这些发现对于开发针对血管屏障功能障碍疾病的精确有效的治疗方法非常重要。